Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes.

Thejasvi Thiruvoipati, Caitlin E Kielhorn, Ehrin J Armstrong
Author Information
  1. Thejasvi Thiruvoipati: Thejasvi Thiruvoipati, Caitlin E Kielhorn, Ehrin J Armstrong, Section of Cardiology, Denver VA Medical Center and University of Colorado School of Medicine, Denver, CO 80220, United States.
  2. Caitlin E Kielhorn: Thejasvi Thiruvoipati, Caitlin E Kielhorn, Ehrin J Armstrong, Section of Cardiology, Denver VA Medical Center and University of Colorado School of Medicine, Denver, CO 80220, United States.
  3. Ehrin J Armstrong: Thejasvi Thiruvoipati, Caitlin E Kielhorn, Ehrin J Armstrong, Section of Cardiology, Denver VA Medical Center and University of Colorado School of Medicine, Denver, CO 80220, United States.

Abstract

Peripheral artery disease (PAD) is the atherosclerosis of lower extremity arteries and is also associated with atherothrombosis of other vascular beds, including the cardiovascular and cerebrovascular systems. The presence of diabetes mellitus greatly increases the risk of PAD, as well as accelerates its course, making these patients more susceptible to ischemic events and impaired functional status compared to patients without diabetes. To minimize these cardiovascular risks it is critical to understand the pathophysiology of atherosclerosis in diabetic patients. This, in turn, can offer insights into the therapeutic avenues available for these patients. This article provides an overview of the epidemiology of PAD in diabetic patients, followed by an analysis of the mechanisms by which altered metabolism in diabetes promotes atherosclerosis and plaque instability. Outcomes of PAD in diabetic patients are also discussed, with a focus on diabetic ulcers and critical limb ischemia.

Keywords

References

  1. Biochem Biophys Res Commun. 1987 Nov 13;148(3):1482-9 [PMID: 2825688]
  2. Ann Intern Med. 2004 Sep 21;141(6):421-31 [PMID: 15381515]
  3. Life Sci. 2000 Jun 8;67(3):291-300 [PMID: 10983873]
  4. J Biomech. 2005 Oct;38(10):1949-71 [PMID: 16084198]
  5. J Clin Invest. 1997 Sep 1;100(5):1230-9 [PMID: 9276741]
  6. J Diabetes Sci Technol. 2014 May;8(3):581-9 [PMID: 24876623]
  7. J Am Coll Cardiol. 2006 Mar 7;47(5):921-9 [PMID: 16516072]
  8. Diabetes. 1996 Jan;45(1):105-7 [PMID: 8522053]
  9. Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:179-217 [PMID: 22271740]
  10. Vasc Med. 2008 Aug;13(3):209-15 [PMID: 18687757]
  11. Br J Pharmacol. 2000 Jul;130(5):963-74 [PMID: 10882379]
  12. JAMA. 2001 Sep 19;286(11):1317-24 [PMID: 11560536]
  13. Circulation. 2002 Oct 1;106(14 ):1783-7 [PMID: 12356630]
  14. Atherosclerosis. 2008 Mar;197(1):237-41 [PMID: 17485096]
  15. Circulation. 1996 Dec 1;94(11):3026-49 [PMID: 8941154]
  16. Diabetes. 1988 Jun;37(6):780-6 [PMID: 2838353]
  17. Diabetes. 2000 Sep;49(9):1561-70 [PMID: 10969841]
  18. Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1664-8 [PMID: 15242864]
  19. J Clin Endocrinol Metab. 2012 Aug;97(8):2862-71 [PMID: 22639289]
  20. Circulation. 2003 Sep 23;108(12):1527-32 [PMID: 14504252]
  21. Arterioscler Thromb. 1991 Jul-Aug;11(4):1068-76 [PMID: 2065028]
  22. J Diabetes Complications. 2001 Jan-Feb;15(1):44-54 [PMID: 11259926]
  23. N Engl J Med. 1998 Jul 23;339(4):229-34 [PMID: 9673301]
  24. Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):998-1005 [PMID: 15001455]
  25. Eur J Vasc Endovasc Surg. 2014 Oct;48(4):447-51 [PMID: 25116276]
  26. Circulation. 1993 Dec;88(6):2510-6 [PMID: 8080489]
  27. Am Heart J. 1999 Nov;138(5 Pt 2):S419-20 [PMID: 10539839]
  28. Vasc Med. 2014 Dec;19(6):465-72 [PMID: 25358555]
  29. Diabetes Metab Res Rev. 2000 Sep-Oct;16 Suppl 1:S11-5 [PMID: 11054881]
  30. J Cardiovasc Surg (Torino). 2009 Jun;50(3):263-73 [PMID: 19543188]
  31. Lancet. 2013 Oct 19;382(9901):1329-40 [PMID: 23915883]
  32. Am J Physiol Heart Circ Physiol. 2001 Apr;280(4):H1480-9 [PMID: 11247757]
  33. Eur J Clin Invest. 1990 Apr;20(2):166-70 [PMID: 2112481]
  34. Vasc Med. 2003 Nov;8(4):237-42 [PMID: 15125483]
  35. Diabetes. 2008 Oct;57(10 ):2818-23 [PMID: 18633114]
  36. Am J Med Sci. 2005 Dec;330(6):263 [PMID: 16355008]
  37. Diabetes Care. 2004 May;27(5):1047-53 [PMID: 15111519]
  38. J Vasc Surg. 2007 Apr;45(4):751-61 [PMID: 17306950]
  39. J Atheroscler Thromb. 1998;5(1):29-35 [PMID: 10077455]
  40. Circ Res. 2010 Oct 29;107(9):1058-70 [PMID: 21030723]
  41. Diabetologia. 1999 Dec;42(12):1383-94 [PMID: 10651255]
  42. Circulation. 1998 Feb 10;97(5):425-8 [PMID: 9490235]
  43. Diabetes Care. 2003 Dec;26(12):3333-41 [PMID: 14633825]
  44. Eur Heart J. 2013 Aug;34(31):2436-43 [PMID: 23641007]
  45. Circ Res. 1996 Feb;78(2):225-30 [PMID: 8575065]
  46. Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1370-80 [PMID: 12231554]
  47. Vasc Med. 1997;2(3):227-30 [PMID: 9546972]
  48. Circ Res. 2001 Jun 22;88(12):1291-8 [PMID: 11420306]
  49. JAMA. 2002 May 15;287(19):2570-81 [PMID: 12020339]
  50. Vasc Med. 2014 Jun 17;19(4):307-314 [PMID: 24939930]
  51. Circulation. 2001 Jul 17;104(3):365-72 [PMID: 11457759]
  52. J Cardiovasc Risk. 1996 Dec;3(6):501-5 [PMID: 9100085]
  53. J Am Geriatr Soc. 1994 Sep;42(9):923-9 [PMID: 8064098]
  54. Br Heart J. 1993 May;69(5):377-81 [PMID: 8518056]
  55. J Vasc Surg. 2000 Jan;31(1 Pt 2):S1-S296 [PMID: 10666287]
  56. Diabetologia. 2009 Nov;52(11):2251-63 [PMID: 19636529]
  57. Diabetologia. 2002 May;45(5):623-34 [PMID: 12107742]
  58. Rev Endocr Metab Disord. 2010 Mar;11(1):75-86 [PMID: 20221852]
  59. Clin Res Cardiol. 2008 Oct;97(10):753-9 [PMID: 18491170]
  60. Am J Med Sci. 2005 Dec;330(6):273-9 [PMID: 16355011]
  61. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2839-43 [PMID: 2704749]
  62. Endocrinol Metab Clin North Am. 2006 Sep;35(3):491-510, vii-viii [PMID: 16959582]
  63. Diabetes Care. 1999 Mar;22(3):453-8 [PMID: 10097928]
  64. JAMA. 2001 Jul 18;286(3):327-34 [PMID: 11466099]
  65. Eur J Vasc Endovasc Surg. 2006 Jul;32(1):51-9 [PMID: 16488631]
  66. Clin Sci (Lond). 2010 Jun 08;119(6):225-38 [PMID: 20545627]
  67. Circulation. 1985 Mar;71(3):516-22 [PMID: 3156007]
  68. Thromb Res. 1992 Sep 15;67(6):643-54 [PMID: 1440530]
  69. Diabetologia. 1995 Jan;38(1):86-96 [PMID: 7744233]
  70. Diabetes Care. 2014 Feb;37(2):409-18 [PMID: 24089537]
  71. Int J Low Extrem Wounds. 2014 Dec;13(4):347-62 [PMID: 25123371]
  72. Diabetes. 2001 Apr;50(4):851-60 [PMID: 11289052]
  73. N Engl J Med. 1990 Jun 21;322(25):1769-74 [PMID: 2345567]
  74. Diabetes Res Clin Pract. 2012 Mar;95(3):364-71 [PMID: 22104261]
  75. Vasc Endovascular Surg. 2005 Nov-Dec;39(6):519-24 [PMID: 16382273]
  76. J Am Geriatr Soc. 1985 Jan;33(1):13-8 [PMID: 3965550]
  77. Diabetes Care. 2001 Aug;24(8):1476-85 [PMID: 11473089]
  78. Diabetes Care. 2001 Aug;24(8):1433-7 [PMID: 11473082]
  79. Arterioscler Thromb Vasc Biol. 1995 Aug;15(8):1114-20 [PMID: 7627704]
  80. Cardiovasc Res. 1998 Mar;37(3):586-600 [PMID: 9659442]
  81. Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:27-9 [PMID: 22271719]
  82. Amino Acids. 2012 Apr;42(4):1163-70 [PMID: 20957396]
  83. Circ J. 2003 Jan;67(1):61-7 [PMID: 12520154]
  84. Circulation. 2013 Oct 8;128(15):1675-85 [PMID: 24100481]
  85. Am J Cardiol. 1999 May 13;83(9B):25F-29F [PMID: 10357572]

Word Cloud

Created with Highcharts 10.0.0patientsPADdiabeticPeripheralarterydiseaseatherosclerosisdiabetesalsocardiovascularcriticalmechanismsOutcomesEpidemiologylowerextremityarteriesassociatedatherothrombosisvascularbedsincludingcerebrovascularsystemspresencemellitusgreatlyincreasesriskwellacceleratescoursemakingsusceptibleischemiceventsimpairedfunctionalstatuscomparedwithoutminimizerisksunderstandpathophysiologyturncanofferinsightstherapeuticavenuesavailablearticleprovidesoverviewepidemiologyfollowedanalysisalteredmetabolismpromotesplaqueinstabilitydiscussedfocusulcerslimbischemiadiabetes:outcomesDiabetesPathophysiology

Similar Articles

Cited By